PRESS-RELEASE ·Filed Jul 22, 2026
Press release · Earnings
Final — all horizons settled through T+60d
CARL ▲ +26.82% at T+60d
NEUTRAL call +26.82% · α vs SPY +22.27% · entry $11.00 → $13.95
T+1d
-1.82%
call -1.82% · α -1.92%
$10.80
settled 3mo ago
T+5d
+15.09%
call +15.09% · α +14.62%
$12.66
settled 3mo ago
T+20d
+50.00%
call +50.00% · α +46.69%
$16.50
settled 2mo ago
T+60d
+26.82%
call +26.82% · α +22.27%
$13.95
settled 12d ago
Price Chart
Loading chart...
Executive Summary
Carlsmed announced it will report its Q2 2026 results on August 5, 2026.
Key Facts
- Carlsmed announced it will report its Q2 2026 results on August 5, 2026.
Market Snapshot
Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
91% bullish (11 analysts)
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3331683 |
6 reports for CARL
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $13.85 | awaiting T+20 | — | $14.91 (+7.65%) |
Sep 30, 2026 26d ago | 8-K | $14.07 | awaiting T+20 | — | $14.91 (+5.97%) |
Sep 28, 2026 28d ago | Press Release | $14.18 $14.91 | ▲ +5.15% | ▲ +5.18% | $14.91 (+5.15%) |
Sep 15, 2026 5w ago | Insider Buy | $15.31 $14.47 | ▼ −5.49% | ▼ −8.66% | $14.91 (−2.61%) |
Aug 24, 2026 9w ago | EFFECT | $15.80 $15.42 | ▼ −2.41% | ▼ −3.72% | $14.91 (−5.63%) |
Jul 22, 2026 13w ago | Press Release | $11.00 $16.50 | ▲ +50.00% | ▲ +46.69% | $14.91 (+35.55%) |
Showing 6 of 6
US Market Status
Market Closed — Opens in 8h 13m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers